Back
Lyell Immunopharma, Inc. LYEL · SEC Filings
website
Lyell Immunopharma, Inc., a clinical-stage cell therapy company, develops chimeric antigen receptor ...161
Price15.42
Market Cap493.65 M
Float18.84 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
Search in Documents